EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.

Conclusions - EPs 7630 is efficacious in children <6 years suffering from AB. The analyses also support the effectiveness of the product in ATP and in ARS. No safety concerns were identified. PMID: 29119837 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research